C Zaugg, J Behringer, M Walther, M Köhler.
Spitalapotheke, Kantonsspital Aarau; Klinik für Kinder und Jugendliche, Kantonsspital Aarau
Introduction: for children, many drugs are used without marketing authorization (“unlicensed”, e.g. imported drugs, drugs prepared by a pharmacy) or outside the terms of marketing authorization (“off-label”). In Switzerland, around half of all prescriptions for paediatric inpatients were either off-label or unlicensed [1].
Purpose: to determine the proportion of unlicensed and off-label prescriptions at discharge, which has not been investigated previously, and the proportion of parents informed about such a prescription.
Materials and methods: prospective study including all discharge prescriptions of inpatients over a two-month period at the Children’s Hospital of Aarau. Exclusion criteria: hospitalisation for chemotherapy only, age over 18, re-entry during study period, no informed consent of parents. At discharge parents were asked to fill in a questionnaire about the information they got on discharge medicines as well as about their satisfaction with this information. This questionnaire was available in German, French, Croatian, Turkish, Albanian, Spanish and English.
Results: during the study period 503 children were discharged, 231 children could be included. Discharge prescriptions were written for 140 children (61%). A total of 227 drugs were prescribed, especially anti-infl ammatory/analgesic, anti-asthmatic and anti-infective drugs. 38.5% of all prescriptions were off-label, regarding dosage in 51%, age in 40% and indication in 9% of all cases. Only 0.5% of drugs were unlicensed. Discharge questionnaires were returned by 103 of 140 children. Most parents (>80%) were informed about purpose, dosage and use of the drugs for their child, and satisfi ed with obtained information, but only 9% of parents getting an off-label/unlicensed prescription for their child were informed about the off-label/unlicensed use.
Conclusions: there is a high percentage of drugs prescribed offlabel at hospital discharge. Most drugs are well known substances and regularly prescribed for children. This emphasises the need toupdate marketing information for older substances, or the need for a national database for drug use and dosage in children.
Reference: 1. Paolo, E et al, 2006. Swiss. Med. WKLY. 136, 218–222.
No conflict of interest.
Eur J Hosp Pharm 2013;20(Suppl 1):A1–238
Spitalapotheke, Kantonsspital Aarau; Klinik für Kinder und Jugendliche, Kantonsspital Aarau
Introduction: for children, many drugs are used without marketing authorization (“unlicensed”, e.g. imported drugs, drugs prepared by a pharmacy) or outside the terms of marketing authorization (“off-label”). In Switzerland, around half of all prescriptions for paediatric inpatients were either off-label or unlicensed [1].
Purpose: to determine the proportion of unlicensed and off-label prescriptions at discharge, which has not been investigated previously, and the proportion of parents informed about such a prescription.
Materials and methods: prospective study including all discharge prescriptions of inpatients over a two-month period at the Children’s Hospital of Aarau. Exclusion criteria: hospitalisation for chemotherapy only, age over 18, re-entry during study period, no informed consent of parents. At discharge parents were asked to fill in a questionnaire about the information they got on discharge medicines as well as about their satisfaction with this information. This questionnaire was available in German, French, Croatian, Turkish, Albanian, Spanish and English.
Results: during the study period 503 children were discharged, 231 children could be included. Discharge prescriptions were written for 140 children (61%). A total of 227 drugs were prescribed, especially anti-infl ammatory/analgesic, anti-asthmatic and anti-infective drugs. 38.5% of all prescriptions were off-label, regarding dosage in 51%, age in 40% and indication in 9% of all cases. Only 0.5% of drugs were unlicensed. Discharge questionnaires were returned by 103 of 140 children. Most parents (>80%) were informed about purpose, dosage and use of the drugs for their child, and satisfi ed with obtained information, but only 9% of parents getting an off-label/unlicensed prescription for their child were informed about the off-label/unlicensed use.
Conclusions: there is a high percentage of drugs prescribed offlabel at hospital discharge. Most drugs are well known substances and regularly prescribed for children. This emphasises the need toupdate marketing information for older substances, or the need for a national database for drug use and dosage in children.
Reference: 1. Paolo, E et al, 2006. Swiss. Med. WKLY. 136, 218–222.
No conflict of interest.
Eur J Hosp Pharm 2013;20(Suppl 1):A1–238
Nenhum comentário:
Postar um comentário